&Partners’s Baxter International BAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$736K Buy
43,621
+12,530
+40% +$243K ﹤0.01% 1474
2025
Q4
$593K Sell
31,091
-6,012
-16% -$120K ﹤0.01% 1516
2025
Q3
$845K Buy
37,103
+6,029
+19% +$153K 0.01% 1168
2025
Q2
$940K Buy
31,074
+2,419
+8% +$73.3K 0.01% 1013
2025
Q1
$966K Buy
28,655
+7,746
+37% +$253K 0.01% 849
2024
Q4
$616K Sell
20,909
-4,488
-18% -$151K 0.01% 984
2024
Q3
$964K Buy
25,397
+16,125
+174% +$592K 0.02% 582
2024
Q2
$310K Buy
+9,272
New +$342K 0.01% 699

Other funds holding BAX

&Partners's BAX Position: Q1 2026 in Review

&Partners increased its Baxter International (BAX) stake by 40% in Q1 2026, buying an estimated $243K and bringing the position to 43,621 shares worth $736K. The position accounts for ﹤0.01% of the portfolio, ranked #1474.

&Partners first reported a position in BAX in Q2 2024 and has held it in 8 quarters since. The position peaked at $966K in Q1 2025. 658 funds tracked by Wall St. Rank hold BAX as of Q1 2026.

  • &Partners held 43,621 shares of Baxter International worth $736K as of Q1 2026.
  • &Partners bought 12,530 Baxter International shares in Q1 2026, an estimated $243K.
  • Baxter International made up ﹤0.01% of &Partners's portfolio in Q1 2026, its #1474 holding.
  • &Partners first reported a position in Baxter International in Q2 2024 and has held it in 8 quarters since.
  • &Partners's Baxter International position peaked at $966K in Q1 2025.
  • 658 funds tracked by Wall St. Rank held Baxter International as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.